NAGL MedTech™ Announces Veronica McDougall as New Chief Executive Officer

NAGL MedTech™ is pleased to announce the promotion of Veronica McDougall to Chief Executive Officer.

This is an exciting transition for the company and Veronica is poised for success in this new role. She has worked for the company for almost 10 years, serving most recently as Vice President of Product Development.

Veronica has been a critical part of the company’s success, serving as a valued member of the executive team, and supporting the Vision and Mission of the company from the start. For the past couple of years, Veronica has been running much of the company’s operations as Head of the Project Lifecycle Management Department (PLMT). She has used her innovative problem-solving strengths to directly lead and oversee successful cross-functional projects to deliver on business objectives. Veronica has demonstrated a firm understanding of running a growing and profitable MedTech service business by providing exceptional client experience, expertise in medical device company management, and expertise in cost-effective medical device product development in a wide variety of medical specialties. As such, she is well equipped to lead NAGL MedTech™ to continued business success.

Before her tenure at NAGL MedTech™, Veronica worked at SafeStitch Medical as a Quality Assurance Engineer and a Regulatory Affairs Associate. Prior to that, she worked at Cordis, a Johnson & Johnson company, as a Senior Engineer in Operations, a Manufacturing and Production Engineer II, and a Process Development Engineer I & II.

Veronica has a B.S. in Mathematics and a minor in Spanish language from Stetson University. Additionally, she studied abroad at Universidad Complutense in Madrid, Spain.

Brett Naglreiter will continue to serve as President of the company and support Veronica in meeting the company’s business objectives.

We are excited about this new chapter for NAGL MedTech™!

Back to News